Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time
- 20 February 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 79 (4) , 374-382
Abstract
During the last decade, there has been a dramatic increase in intravenous drug use in young adults in Estonia with an increased incidence of both hepatitis B and C as a consequence. Since genetic data are limited regarding hepatitis C virus (HCV) strains in Estonia, the aim of the study was to characterize HCV strains in different risk groups to determine their relatedness to strains from other geographical regions. Three hundred fifty‐three anti‐HCV positive sera collected during 1994–2004 from hospitalized patients, blood donors and health care workers were used as source of HCV RNA. Two hundred nine (59%) of the sera were positive for HCV RNA by PCR directed to the 5′‐UTR region. For 174 strains the HCV subtype was determined by analyses of the NS5B and/or the 5′UTR‐core regions. 1b (71%) was the most common subtype followed by 3a (24%), 2c (2%), 1a (1%), and 2a (1%). The 1b and 3a strains were similar to strains from other regions of the former USSR. Within genotype 1b there were several HCV lineages. However, for 3a there seemed to be two separate introductions into Estonia. There was a relative shift from subtype 1b to 3a in 1999–2000 with a further replacement of 3a with 1b in intravenous drug users in 2001 and onwards (P < 0.05). However, both subtypes were found to co‐circulate in the community independent of risk factors. One patient was infected with the 2k/1b recombinant presumed to originate from St. Petersburg being the first isolate of this recombinant recovered outside Russia. J. Med. Virol. 79:374–382, 2007.Keywords
This publication has 39 references indexed in Scilit:
- Molecular epidemiology of the hepatitis C virus in Western SiberiaJournal of Medical Virology, 2005
- Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII StudyJournal of Viral Hepatitis, 2005
- Changes in the Prevalence of Hepatitis C Virus Genotype among Injection Drug Users: A Highly Dynamic ProcessThe Journal of Infectious Diseases, 2004
- Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B regionJournal of Medical Virology, 2004
- A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. PetersburgJournal of Virology, 2002
- Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use*Journal of Medical Virology, 2001
- The Influence of Age on the Prevalence of Hepatitis C Virus Subtypes 1a and 1bThe Journal of Infectious Diseases, 1997
- Prevalence of Hepatitis C Genotypes among Patients with Chronic Hepatitis C in NorwayScandinavian Journal of Infectious Diseases, 1996
- Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sourcesJournal of General Virology, 1992
- Enhanced detection by PCR of hepatitis C virus RNAThe Lancet, 1990